I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage ...

Cancer screening is at a turning point. For decades, most tests focused on one form of the disease — like mammograms for breast cancer or colonoscopies for colorectal cancer — but new advances have ...

With March being colon cancer awareness month, it’s a good time to look at some startling numbers on the disease here in the United States. Once considered only a medical concern for middle-age or ...

Scientists at Pitt developed BiliSeq in 2019, a molecular test that detects both DNA and RNA sequences in biopsy samples to ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

A Miami man credits a routine blood test with saving his life after early-stage colon cancer was found via colonoscopy, ...

If an at-home, cancer-detection test sounds too good to be true, there’s a chance that it is. Called multicancer detection (MCD) tests, they check a person’s blood or other body fluids (such as urine ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...